☆ 4.7 Article

'Stealth' corporate innovation: an emerging threat for therapeutic drug development

NATURE IMMUNOLOGY (2019)

Get Full Text
Add to Collection

Journal

NATURE IMMUNOLOGY
Volume 20, Issue 11, Pages 1409-1413

Publisher

NATURE RESEARCH
DOI: 10.1038/s41590-019-0503-1

Keywords

-

Categories

Immunology

Funding

  1. Roche Pharma
  2. Orion Pharma
  3. Genmab
  4. Merus
  5. Alexion
  6. Hansa Medical
  7. GuidePoint Global, Sucampo
  8. Immune Tolerance Network
  9. GSK
  10. Alexion Pharmaceuticals
  11. Novartis
  12. Alnylam
  13. Roche
  14. Samsung
  15. Amyndas Pharmaceuticals [(1MeW)7W/POT-4/APL-1]
  16. Baxter
  17. MRC [UKDRI-3002] Funding Source: UKRI

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.